-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNIC INC - TRIAL ACHIEVED PRIMARY AND SECONDARY ENDPOINTS WITH HIGH SIGNIFICANCE

Reuters·06/24/2025 10:30:02

Please log in to view news